<DOC>
	<DOC>NCT03044002</DOC>
	<brief_summary>Controlled, multicenter, non-inferiority trial to compare the rate of access site complications (ASC) in 4French (4F) vs. 6French (6F) femoral access endovascular interventions.</brief_summary>
	<brief_title>BIOTRONIK 4French for AMBulatory Peripheral Intervention</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>Age ≥ 18 years or minimum age as required by local regulations Ability to walk Subject must be willing to sign patient Informed Consent (PIC) Patient with infrainguinal arteries lesion(s) suitable to be treated during an ambulatory endovascular intervention No possibility of an ambulatory management Physical fitness classified as ASA ≥ 4 (American Society of Anaesthesiologists) Coagulation disorders Acute ischemia Less than 1month live expectancy Pregnant or breast feeding females or females who intend to become pregnant during the time of the study (pregnancy test required for all women with child bearing potential) Subject currently enrolled in other medical or drug study and has not reached the primary outcome measures Patient contraindicated for antiplatelet therapy, anticoagulants and antithrombotics Other access than common femoral Home alone the first night</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>